Putnam Investments LLC Axonics, Inc. Transaction History
Putnam Investments LLC
- $73 Billion
- Q4 2023
A detailed history of Putnam Investments LLC transactions in Axonics, Inc. stock. As of the latest transaction made, Putnam Investments LLC holds 239,360 shares of AXNX stock, worth $17 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
239,360
Previous 176,691
35.47%
Holding current value
$17 Million
Previous $9.92 Million
50.23%
% of portfolio
0.02%
Previous 0.02%
Shares
11 transactions
Others Institutions Holding AXNX
# of Institutions
17Shares Held
5.03MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY4.34MShares$308 Million0.01% of portfolio
-
Segantii Capital Management LTD165KShares$11.7 Million1.41% of portfolio
-
Credit Suisse Ag Zurich, V899.6KShares$7.07 Million0.01% of portfolio
-
Eisler Capital (Uk) Ltd. London, X098.5KShares$6.99 Million0.03% of portfolio
-
Virginia Retirement Systems Et Al Richmond, VA31.8KShares$2.26 Million0.02% of portfolio
About Axonics, Inc.
- Ticker AXNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 49,123,600
- Market Cap $3.49B
- Description
- Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...